This inventor holds 7 USPTO granted patents, plus 4 CIPO patents and 2 EPO patents. Top assignees: Phyton Holdings, LLC, Natural Pharmaccuticals, Inc., Natural Pharmaceuticals, Inc.. Active years: 2005-2018.
Location History:
- Gloucester, MA (US) (2005 - 2009)
- Kingston, NH (US) (2011 - 2018)
Company Filing History:
5 out of 15 
1 out of 1 
1 out of 3 Years Active: 2005-2018
Title: John S. Juchum: Innovator in Taxane Purification
Introduction
John S. Juchum is a prominent inventor based in Kingston, NH, USA. With an impressive portfolio of seven patents, he has made significant contributions to the field of pharmaceutical sciences, particularly in the purification of taxanes, which are crucial compounds in cancer treatment.
Latest Patents
Among his latest innovations, John Juchum has developed methods for crystallizing docetaxel, a taxane used in chemotherapy. One of his patents involves a process where docetaxel is combined with solubilizing solvents such as acetone, methyl-tert-butyl ether, tetrahydrofuran (THF), or acetonitrile. Following this, he introduces an anti-solvent, specifically water, to achieve crystalline docetaxel. Another similar patent outlines the use of methylene chloride as a solubilizing solvent before adding water as the anti-solvent to crystallize docetaxel.
Career Highlights
Juchum's career is marked by his work with notable companies in the pharmaceutical sector. He has been associated with Phyton Holdings, LLC and Natural Pharmaceuticals, Inc., where he contributed his expertise in drug formulation and purification techniques. His innovative approaches have been instrumental in enhancing the efficiency of cancer therapies.
Collaborations
Throughout his career, John has collaborated with distinguished professionals, including Rex T. Gallagher and James Harvey Johnson. These collaborations have furthered his research and development efforts, leading to significant advancements in taxane purification methods.
Conclusion
John S. Juchum's contributions to the field of pharmaceuticals, especially in the area of taxane purification, highlight his status as an influential inventor. With his seven patents, he continues to impact the development of effective cancer treatments, showcasing the vital role of innovation in enhancing patient outcomes.